Charlie Hospital Semarang Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp156 (market cap 282.02B, 78.69M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 2.6× Trimegah Karya Pratama Tbk.'s market cap, and Trimegah Karya Pratama Tbk. is more actively traded (78.69M versus 29.45M). Which is the better fit depends on your goals.
| RSCH | UVCR | |
|---|---|---|
Market Cap | 742B | 282.02B |
Volume | 29.45M | 78.69M |
Lot | 294.49K | 786.86K |
Turnover | 8.14B | 11.63B |
Average Price | 276.35 | 147.78 |
Value | 8.14B | 11.63B |
Indicative Equilibrium Price | 270 | 156 |
Indicative Equilibrium Volume | 103 | 11.45K |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →